 | • レポートコード：MRC2103G013 • 出版社/出版日：Transparency Market Research / 2020年10月16日 • レポート形態：英文、PDF、200ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の心肺ストレステストシステム市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品タイプ別（心肺運動検査（CPET）システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射断層撮影（SPECT））分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・心肺ストレステストシステムの世界市場規模：製品タイプ別（心肺運動検査（CPET）システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射断層撮影（SPECT）） ・心肺ストレステストシステムの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Global Cardiopulmonary Stress Testing Systems Market – Scope of Report
TMR’s report on the global cardiopulmonary stress testing systems market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cardiopulmonary stress testing systems market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiopulmonary stress testing systems market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiopulmonary stress testing systems market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiopulmonary stress testing systems market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cardiopulmonary stress testing systems market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiopulmonary stress testing systems market.
The report delves into the competitive landscape of the global cardiopulmonary stress testing systems market. Key players operating in the global cardiopulmonary stress testing systems market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiopulmonary stress testing systems market that have been profiled in this report.
Key Questions Answered in Global Cardiopulmonary Stress Testing Systems Market Report
What is the scope of growth of product companies in the global cardiopulmonary stress testing systems market?
What will be the Y-o-Y growth of the global cardiopulmonary stress testing systems market between 2019 and 2027?
What is the influence of changing trends in technologies on the global cardiopulmonary stress testing systems market?
Will North America continue to be the most profitable market for cardiopulmonary stress testing systems providers?
Which factors are anticipated to hamper the growth of the global cardiopulmonary stress testing systems market during the forecast period?
Which are the leading companies in the global cardiopulmonary stress testing systems market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cardiopulmonary stress testing systems market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global cardiopulmonary stress testing systems market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the cardiopulmonary stress testing systems market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cardiopulmonary stress testing systems market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cardiopulmonary stress testing systems market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global cardiopulmonary stress testing systems market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe
5.2. Pricing Analysis
5.3. Epidemiology of Coronary Artery Disease, by Key Countries
6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Product Type, 2017–2027
6.2.1. CPET Systems
6.2.1.1. Stationary
6.2.1.2. Portable
6.2.2. Stress ECG
6.2.3. Pulse Oximeters
6.2.4. Stress BP Monitors
6.2.5. Single-Photon Emission Computed Tomography (SPECT)
6.3. Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type
7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Region
8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
8.2.1. CPET Systems
8.2.1.1. Stationary
8.2.1.2. Portable
8.2.2. Stress ECG
8.2.3. Pulse Oximeters
8.2.4. Stress BP Monitors
8.2.5. Single-Photon Emission Computed Tomography (SPECT)
8.3. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017–2027
8.3.1. U.S.
8.3.2. Canada
8.4. North America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis
8.4.1. By Product Type
8.4.2. By Country
9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
9.2.1. CPET Systems
9.2.1.1. Stationary
9.2.1.2. Portable
9.2.2. Stress ECG
9.2.3. Pulse Oximeters
9.2.4. Stress BP Monitors
9.2.5. Single-Photon Emission Computed Tomography (SPECT)
9.3. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis
9.4.1. By Product Type
9.4.2. By Country/Sub-region
10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
10.2.1. CPET Systems
10.2.1.1. Stationary
10.2.1.2. Portable
10.2.2. Stress ECG
10.2.3. Pulse Oximeters
10.2.4. Stress BP Monitors
10.2.5. Single-Photon Emission Computed Tomography (SPECT)
10.3. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By Country/Sub-region
11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
11.2.1. CPET Systems
11.2.1.1. Stationary
11.2.1.2. Portable
11.2.2. Stress ECG
11.2.3. Pulse Oximeters
11.2.4. Stress BP Monitors
11.2.5. Single-Photon Emission Computed Tomography (SPECT)
11.3. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America Latin America
11.4. Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis
11.4.1. By Product Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
12.2.1. CPET Systems
12.2.1.1. Stationary
12.2.1.2. Portable
12.2.2. Stress ECG
12.2.3. Pulse Oximeters
12.2.4. Stress BP Monitors
12.2.5. Single-Photon Emission Computed Tomography (SPECT)
12.3. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis
12.4.1. By Product Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (by Tier and Size of companies)
13.2. Market Share / Position Analysis, by Company, 2018
13.3. Company Profiles
13.3.1. General Electric Company
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Overview
13.3.1.3. Strategic Overview
13.3.1.4. SWOT Analysis
13.3.2. Koninklijke Philips N.V.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Overview
13.3.2.3. Strategic Overview
13.3.2.4. SWOT Analysis
13.3.3. CareFusion Corporation (BD)
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Overview
13.3.3.3. Strategic Overview
13.3.3.4. SWOT Analysis
13.3.4. Spacelabs Healthcare (OSI Systems, Inc.)
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Overview
13.3.4.3. Strategic Overview
13.3.4.4. SWOT Analysis
13.3.5. COSMED srl
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Overview
13.3.5.3. Strategic Overview
13.3.5.4. SWOT Analysis
13.3.6. MGC Diagnostic Corporation
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Overview
13.3.6.3. Strategic Overview
13.3.6.4. SWOT Analysis
13.3.7. Nihon Kohden Corporation
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Overview
13.3.7.3. Strategic Overview
13.3.7.4. SWOT Analysis
13.3.8. Schiller AG
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Overview
13.3.8.3. Strategic Overview
13.3.8.4. SWOT Analysis
13.3.9. SunTech Medical, Inc.
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Overview
13.3.9.3. Strategic Overview
13.3.9.4. SWOT Analysis
13.3.10. Welch Allyn
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Overview
13.3.10.3. Strategic Overview
13.3.10.4. SWOT Analysis
Table 01.Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 07.Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 08.North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09.North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15.Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16.Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 22.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 29.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 31.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Passive Approximators, 2017–2027
Table 36.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 37.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027